Article Details

Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A ...

Retrieved on: 2021-03-31 09:33:45

Tags for this article:

Click the tags to see associated articles and topics

Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A .... View article details on hiswai:

Excerpt

50 patients received hydroxychloroquine 800 mg at day 1 followed by 200 mg twice (day 2-10) and oral oseltamivir 75 mg/12 h/day for 10 days.

Article found on: www.docwirenews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo